TriSalus Life Sciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-1.7M | $-1.7M | — | — |
| FY2022 | $-32.3M | $-33.0M | $655.0K | $368.0K |
| FY2023 | $-50.6M | $-51.2M | $588.0K | $1.4M |
| FY2024 | $-40.8M | $-41.2M | $345.0K | $5.4M |
| FY2025 | $-18.0M | $-18.9M | $918.0K | $9.1M |